Effects of Sertraline on Sleep Architecture in Patients with Depression

Journal of Clinical Psychopharmacology

Volumn 23, Issue 6, 2003, Pages 540-548

  Jindal, Ripu D ^a   Friedman, Edward S ^a   Berman, Susan R ^a   Fasiczka, Amy L ^a   Howland, Robert H ^a   Thase, Michael E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LATENT PERIOD; MAJOR DEPRESSION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SLEEP; SLEEP PATTERN; SOMNOLENCE;

ADULT; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SLEEP;

EID: 0344896577     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000095345.32154.9a     Document Type: Article

References (37)

1. Mendelson WB. Clinical neuropharmacology of sleep. Neurol Clin. 1990;8(1):153-160.
2. Cartwright RD. Rapid eye movement sleep characteristics during and after mood-disturbing events. Arch Gen Psychiatry. 1983;40:197-201.
3. Rush AJ, Erman MK, Giles DE, et al. Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry. 1986;43:878-884.
4. Thase ME, Reynolds CF III, Jennings JR, et al. Polysomnographic studies of unmedicated depressed men before and after treatment of cognitive behavioral therapy. Am J Psychiatry. 1994;151:1615-1622.
5. Thase ME, Fasiczka AL, Berman SR, et al. Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression. Arch Gen Psychiatry. 1998;55:138-144.
6. Kupfer DJ, Frank E, McEachran AB, et al. Delta sleep ratio. Arch Gen Psychiatry. 1990;47:1100-1105.
7. Thase ME, Simons AD, Reynolds CF III. Abnormal electroencephalographic sleep profiles in major depression. Association with response to cognitive behavior therapy. Arch Gen Psychiatry. 1996;53:99-108.
8. Sharpley AL and Cowan PJ. Effects of pharmacological treatments on sleep of depressed patients. Biol Psychiatry. 1995;37:85-98.
9. Gillin JC, Wyatt RJ, Fram D, et al. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology. 1978;59:267-272.
10. Vogel GW, Vogel F, McAbee RS, et al. Improvement of depression by REM sleep deprivation. New findings and a theory. Arch Gen Psychiatry. 1980;37(3):247-253.
11. Monti JM. Effect of reversible monoamine oxidase-A inhibitor (moclo-bemide) on sleep of depressed patients. Br J Psychiatry. 1989;155:61-65.
12. Rush AJ, Armitage R, Gillin JC, et al. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry. 1998;44(1):3-14.
13. Mendlewicz J, Dunbar GC, Hoffman G. Changes in sleep EEG architecture during treatment of depressed patients with mianserin. Acta Psychiatr Scand. 1985;72(suppl 320):26-29.
14. Nofzinger EA, Reynolds CF III, Thase ME, et al. REM sleep enhancement by bupropion in depressed men. Am J Psychiatry. 1995;152(2): 274-276.
15. Kupfer DJ, Perel JM, Pollock BG, et al. Fluvoxamine versus desipramine: comparative polysomnographic effects. Biol Psychiatry. 1991; 29:23-40.
16. Staner L, Kerkhofs M, Detroux D, et al. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep. 1995;18(6):470-477.
17. Shipley JE, Kupfer DJ, Dealy RS, et al. Differential effects of amitryptyline and of zimelidine on the sleep electroencephalogram of depressed patients. Clin Pharmacol Ther. 1984;36(2):251-259.
18. van Bemmel, AL van den Hoofdakker RH, Beersma DGM, et al. Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology. 1993; 113:225-230.
19. Preskorn SH. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 1995;56(suppl 6):12-21.
20. Winokur A, Sewitch DE, Biniaur IV, et al. Effects of sertraline on sleep architecture in patients with major depression. Clin Neuropharmacol. 1992;15(suppl 1):84B.
21. First MB, Spitzer RL, Gibbons M, et al. Structured clinical interview for DSM-IV axis I disorders-Patient edition (SCID-I/P). New York: New York State Psychiatric Institute; 1995.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
23. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
24. Endicott J, Spitzer RL, Fleiss JL, et al. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766-771.
25. Buysee DJ, Reynolds III CF, Monk TH, et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213.
26. Thase ME, Friedman ES, Berman SR, et al. Is cognitive behavior therapy just a "nonspecific" intervention for depression? A retrospective comparison of consecutive cohorts treated with cognitive behavior therapy or supportive counseling and placebo pill. J Affect Disord. 2000; 57:63-71.
27. Rechtschaffen A, Kales A (eds): A manual of standardized terminology, techniques and scoring for sleep stages of human subjects. NIH publication 204. Washington, DC: Dept of Health, Education and Welfare; 1968.
28. Doman J, Detka C, Hoffman T, et al. Automating the sleep laboratory: implementation and validation of digital recording and analysis. Int J Biomed Comput. 1995;38:277-290.
29. Doman J, Kupfer DJ. Computer analysis of EEG, EOG, and NPT during sleep. Int Biomed Comput. 1988;23:191-200.
30. Buysee DJ, Hall M, Tu XM, et al. Latent structure of EEG sleep variables in depressed and control subjects: descriptions and clinical correlates. Psychiatry Res. 1998;79:105-122 and corrigendum 80:299.
31. Thase ME, Kupfer DJ, Fasiczka AJ, et al. Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder. Biol Psychiatry. 1997;41:964-973.
32. Thase ME, Simons AD, Reynolds CF III. Abnormal electroencephalographic sleep profiles in major depression: association with response to cognitive behavior therapy. Arch Gen Psychiatry. 1996;53:99-108.
33. Thase ME, Buysse DJ, Frank E, et al. Which depressed patients will respond to interpersonal psychotherapy? the role of abnormal EEG sleep profiles. Am J Psychiatry. 1997;154:502-509.
34. Thase ME, Dube S, Bowler K, et al. Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in un-medicated, hospitalized depressed patients. Am J Psychiatry. 1996;153:886-891.
35. Kerkhofs M, Missa JN, Mendlewicz J. Sleep electroencephalographic measures in primary major depressive disorder: distinction between DST suppressor and nonsuppressor patients. Biol Psychiatry. 1986; 21(2):228-232.
36. Mellman TA, Bustamante V, Fins AI, et al. REM sleep and early development of posttraumatic stress disorder. Am J Psychiatry. 2002; 159:1696.
37. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. An analysis of the Food and Drug Administration database. Arch Gen Psychiatry. 2000;57(4):311-317.